Articles by Jill Wechsler - BioPharm International

ADVERTISEMENT

ADVERTISEMENT

Articles by Jill Wechsler

Jill Wechsler


Jill Wechsler is BioPharm International's Washington editor.

Articles
Industry Seeks Clearer Standards for Track and Trace
July 1, 2014

Stakeholders face challenges and benefits from a more secure pharmaceutical supply chain.

Supplier Audit Program Marks Progress
July 1, 2014

Supplier Audit Program Marks Progress

Global Expansion Shapes Drug Oversight
June 1, 2014

Regulators and industry organizations explain policies and standards to manufacturers and authorities in all regions.

Demand for New Vaccines Spurs Innovation
May 1, 2014

New formulations and expanded vaccine production are encouraged.

FDA and Manufacturers Seek a More Secure Drug Supply Chain
April 1, 2014

New identifiers and tracking requirements aim to block illegitimate products.

Manufacturers Struggle with Breakthrough Drug Development
March 1, 2014

Accelerated testing and production create challenges in documenting product quality.

FDA Outlines Agenda for New Guidances in 2014
February 5, 2014

FDA plans to issue a number of new guidances in 2014 that will address drug development and manufacturing practices.

Metrics Sought to Ensure Drug Quality
January 1, 2014

Regulators work with manufacturers to improve systems for measuring product performance and manufacturing reliability.

Super Oversight for Generics
December 12, 2013

OGD is under pressure to improve review operations.

ADVERTISEMENT

ADVERTISEMENT

Click here